This is a community-generated profile. If you would like to claim it, please .
IRX Therapeutics Funding
$26.8M
55 rounds
IRX Therapeutics is active in the following markets / industries: biotechnology. The company has secured funding across 5 rounds, totaling in an amount of $26.8M. Their most recent funding was raised on October 29, 2018.
Funding Rounds
ACQ
Undisclosed amountU
$15100000U
$1500000U
$8000000U
$2200000Investors of IRX Therapeutics
John Heilshorn
Partner at Solon Mack Capital, a family office.
Commercial Real Estate Investor and Analyst, Value Investor and Asset Repostioning
Joseph Swiader
Private investor, Entrepreneur